In the first large-scale study of 5hmC immunoreactivity in PCa patients, we have previously shown that high immunoreactivity of 5hmC is a significant adverse predictor of biochemical failure (BF) following radical prostatectomy (RP) in patients with ERG negative PCas [15,16]. The gene discussed is ERG; the disease is posterior cortical atrophy.